Mednax Valuation
| MD Stock | USD 21.52 0.45 2.14% |
At this time, the firm appears to be fairly valued. Mednax Inc secures a last-minute Real Value of $22.37 per share. The latest price of the firm is $21.52. Our model forecasts the value of Mednax Inc from analyzing the firm fundamentals such as Profit Margin of 0.08 %, return on equity of 0.2, and Current Valuation of 2.03 B as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Mednax's valuation include:
Fairly Valued
Today
Please note that Mednax's price fluctuation is very steady at this time. Calculation of the real value of Mednax Inc is based on 3 months time horizon. Increasing Mednax's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Mednax stock is determined by what a typical buyer is willing to pay for full or partial control of Mednax Inc. Since Mednax is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Mednax Stock. However, Mednax's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 21.52 | Real 22.37 | Target 22.67 | Hype 21.57 |
The real value of Mednax Stock, also known as its intrinsic value, is the underlying worth of Mednax Inc Company, which is reflected in its stock price. It is based on Mednax's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Mednax's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Mednax Inc helps investors to forecast how Mednax stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Mednax more accurately as focusing exclusively on Mednax's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Mednax's intrinsic value based on its ongoing forecasts of Mednax's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Mednax's closest peers. If more than one evaluation category is relevant for Mednax we suggest using both methods to arrive at a better estimate.
Mednax Cash |
|
Mednax Revenue by Product
Mednax Total Value Analysis
Mednax Inc is now forecasted to have takeover value of 2.03 B with market capitalization of 1.87 B, debt of 662.31 M, and cash on hands of 229.94 M. Please note that takeover value may be misleading and is a subject to accounting mistakes. We encourage investors to methodically examine all of the Mednax fundamentals before making investment evaluation based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
2.03 B | 1.87 B | 662.31 M | 229.94 M |
Mednax Investor Information
About 98.0% of the company shares are owned by institutional investors. The book value of Mednax was now reported as 10.59. The company has Price/Earnings To Growth (PEG) ratio of 0.88. Mednax Inc had not issued any dividends in recent years. The entity had 2:1 split on the 20th of December 2013. Based on the key measurements obtained from Mednax's financial statements, Mednax Inc is not in a good financial situation at this time. It has a very high probability of going through financial hardship in March.| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Total Cash From Operating Activities | 211.1 M | 237.6 M |
|
|
Mednax Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Mednax has an asset utilization ratio of 93.51 percent. This indicates that the Company is making $0.94 for each dollar of assets. An increasing asset utilization means that Mednax Inc is more efficient with each dollar of assets it utilizes for everyday operations.Mednax Profitability Analysis
Based on the key profitability measurements obtained from Mednax's financial statements, Mednax Inc may not be well positioned to generate adequate gross income at this time. It has a very high probability of underperforming in March. Profitability indicators assess Mednax's ability to earn profits and add value for shareholders.Net Loss | First Reported 1994-03-31 | Previous Quarter 39.3 M | Current Value 71.7 M | Quarterly Volatility 136.7 M |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Gross Profit Margin | 0.25 | 0.26 |
|
|
For Mednax profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Mednax Inc to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Mednax utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Mednax's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Mednax over time as well as its relative position and ranking within its peers.
Mednax Earnings per Share Projection vs Actual
The next projected EPS of Mednax is estimated to be 0.546675 with future projections ranging from a low of 0.5275 to a high of 0.597475. Mednax's most recent 12-month trailing earnings per share (EPS TTM) is at 1.91. Please be aware that the consensus of earnings estimates for Mednax Inc is based on EPS before non-recurring items and includes expenses related to employee stock options.Mednax Earnings Estimation Breakdown
The calculation of Mednax's earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of Mednax is estimated to be 0.546675 with the future projection ranging from a low of 0.5275 to a high of 0.597475. Please be aware that this consensus of annual earnings estimates for Mednax Inc is based on EPS before non-recurring items and includes expenses related to employee stock options.Last Reported EPS
0.53 Lowest | Expected EPS | 0.60 Highest |
Mednax Earnings Projection Consensus
Suppose the current estimates of Mednax's value are higher than the current market price of the Mednax stock. In this case, investors may conclude that Mednax is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and Mednax's stock will quickly adjusts to the new information provided by the consensus estimate.
| Number of Analysts | Historical Accuracy | Last Reported EPS | Estimated EPS for 31st of December 2026 | Current EPS (TTM) | |
| 7 | 80.97% | 0.0 | 0.546675 | 1.91 |
Mednax Ownership Allocation
The majority of Mednax outstanding shares are owned by institutional investors. These third-party entities are usually referred to as non-private investors looking to shop for positions in Mednax Inc to benefit from reduced commissions. Consequently, institutional holders are subject to a different set of regulations than regular investors in Mednax Inc. Please pay attention to any change in the institutional holdings of Mednax as this could imply that something significant has changed or is about to change at the company.Mednax Profitability Analysis
The company generated the yearly revenue of 2.01 B. Annual Net Loss to common stockholders was (99.07 M) with gross profit of 496.24 M.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Mednax's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Mednax and how it compares across the competition.
About Mednax Valuation
The stock valuation mechanism determines Mednax's current worth on a weekly basis. Our valuation model uses a comparative analysis of Mednax. We calculate exposure to Mednax's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Mednax's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 522.5 M | 528.2 M | |
| Pretax Profit Margin | (0.06) | (0.05) | |
| Operating Profit Margin | (0.04) | (0.04) | |
| Net Loss | (0.06) | (0.05) | |
| Gross Profit Margin | 0.26 | 0.25 |
Mednax Growth Indicators
Investing in growth stocks can be very risky. If the company such as Mednax does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 83.3 M | |
| Quarterly Earnings Growth Y O Y | 2.652 | |
| Forward Price Earnings | 9.0009 |
Mednax Current Valuation Indicators
Valuation refers to the process of determining the present value of Mednax Inc and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Mednax we look at many different elements of the entity such as Mednax's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Mednax, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Mednax's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Mednax's worth.Complementary Tools for Mednax Stock analysis
When running Mednax's price analysis, check to measure Mednax's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mednax is operating at the current time. Most of Mednax's value examination focuses on studying past and present price action to predict the probability of Mednax's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mednax's price. Additionally, you may evaluate how the addition of Mednax to your portfolios can decrease your overall portfolio volatility.
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |